Osmotica Pharmaceuticals plc to Provide Third Quarter 2019 Business and Financial Update on November 15, 2019


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


BRIDGEWATER, N.J., Nov. 08, 2019 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc ("Osmotica" or the "Company") (NASDAQ:OSMT), a fully integrated biopharmaceutical company, today announced that the Company will release its 2019 third quarter financial results on Thursday, November 14, 2019, after the close of the U.S. financial markets.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Brian Markison, Chief Executive Officer, James "JD" Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will host a conference call to discuss the results as follows:

DateFriday, November 15, 2019
Time8:30 a.m. EST
Toll free (U.S.)(866) 672-5029
International(409) 217-8312
Webcast (live and replay)www.osmotica.com under the "Investor & News" section

The webcast will be archived for 30 days at the aforementioned URL.


Want Private Access to Benzinga Analyst?

Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.


About Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. Vertical Pharmaceuticals, LLC represents the Company's diversified branded portfolio, and Trigen Laboratories, LLC represents the non-promoted products including complex generic formulations. 

Osmotica has operations in the United States, Argentina, and Hungary. 

Investor and Media Relations for Osmotica Pharmaceuticals plc
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com 


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: NewsPress Releases